ADHD does look different in males and females, though the differences are more nuanced than many people realize. Boys are diagnosed roughly twice as often as girls, but a growing body of evidence suggests this gap reflects diagnostic bias as much as true prevalence. The ways symptoms show up, the conditions that develop alongside ADHD, and the hormonal factors that influence symptom severity all vary by sex.
The Diagnosis Gap Starts Early
Large population studies estimate the male-to-female ratio for ADHD at about 2.3 to 1, significantly lower than the old estimate of 4 to 1 that dominated textbooks for years. That older number came largely from clinical samples, meaning it reflected who was getting referred and diagnosed rather than who actually had the condition. The ratio stays relatively stable across age groups: about 2.1 to 1 in children and 2.15 to 1 in adults.
A key reason girls slip through the cracks is that ADHD diagnostic criteria were built around the most disruptive children in clinical settings, who were overwhelmingly boys. Until 2013, ADHD was even classified under “Disruptive Behavior Disorders of Childhood” in the diagnostic manual, with hyperactivity as the hallmark feature. It has since been reclassified as a neurodevelopmental disorder, but observable, externalizing behaviors still dominate the criteria over less obvious inattentive symptoms. Parents and teachers are more likely to refer boys for evaluation based on scales designed to flag disruptive behavior, even when girls endorse other ADHD symptoms at similar rates.
How Symptoms Differ by Sex
The traditional picture is that girls with ADHD tend to present with more inattentive symptoms (difficulty focusing, disorganization, forgetfulness) while boys more commonly show the hyperactive-impulsive type (fidgeting, interrupting, acting without thinking). Research supports this pattern in childhood, with girls diagnosed more often with the predominantly inattentive subtype.
In adults, the picture shifts. One study of over 2,200 adults found that men and women did not differ meaningfully in their distribution of ADHD subtypes or severity. Women in that study actually endorsed higher rates of six hyperactivity/impulsivity symptoms compared to childhood patterns, where boys had higher rates. This suggests that the symptom gap between sexes may narrow over time, or that women who finally receive a diagnosis in adulthood have a broader range of symptoms than childhood stereotypes would predict.
Longitudinal research found that men in emerging adulthood had higher inattention symptoms than women but similar levels of hyperactivity-impulsivity. Women showed no significant difference between their inattention and hyperactivity-impulsivity levels, while men’s inattention was notably higher than their hyperactivity-impulsivity. In other words, the common assumption that boys are the hyperactive ones and girls are the inattentive ones is an oversimplification.
The Role of Hormones
One of the clearest biological differences involves estrogen. Estrogen stimulates production of dopamine, the neurotransmitter most closely linked to ADHD, and slows its breakdown at the synapse. It essentially helps keep dopamine levels higher and more stable. When estrogen drops, as it does during the second half of the menstrual cycle, during postpartum, or during perimenopause, the already-disrupted dopamine system in someone with ADHD takes a further hit.
This means women with ADHD often experience a worsening of symptoms that follows a monthly pattern. Focus, emotional regulation, and impulse control can deteriorate in the days before a period, then improve again afterward. These fluctuations can also affect how well stimulant medications work, since those medications target the same dopamine pathways that estrogen influences. Brain regions involved in ADHD, including the prefrontal cortex and basal ganglia, have estrogen receptors, making them particularly sensitive to these hormonal swings.
Different Conditions Travel With ADHD
The conditions that co-occur alongside ADHD follow strikingly different patterns by sex. A population-based study of 40,000 adults found that women with ADHD had higher rates of nearly every psychiatric condition compared to men with ADHD, with the exception of schizophrenia and substance use disorders. Depression was especially divergent: the prevalence difference attributable to ADHD was 24.4% in women versus 13.1% in men. Anxiety and personality disorders also showed larger associations in women.
Men with ADHD, by contrast, had substantially higher rates of substance use disorders (23.0% prevalence difference versus 13.7% in women). The combined subtype of ADHD, which is more common in men, is more frequently linked to antisocial personality disorder and substance use problems. These externalizing patterns tend to be more visible and more likely to trigger a clinical referral, which further contributes to the diagnostic imbalance.
Camouflaging and Its Costs
Girls and women with ADHD are more likely to camouflage their symptoms, a process that involves masking difficulties, actively compensating for them in social situations, and working to assimilate with neurotypical peers. This can look like suppressing fidgeting, imitating social behavior without fully understanding it, developing perfectionistic habits to compensate for disorganization, or simply working far harder than peers to achieve the same results.
Research on neurodivergent adolescent girls found they felt they were “acting or pretending” significantly more often than neurotypical peers. Parents and educators noted that girls could handle superficial social interactions but struggled with deeper reciprocal relationships and friendships. The effort involved is not trivial. Camouflaging scores strongly predicted anxiety and depression in studies of neurodivergent girls, and the negative mental health impact stems from identity confusion, feelings of inadequacy, fatigue and burnout, delayed diagnosis, and inauthentic relationships.
This masking behavior was originally proposed as a central reason neurodivergent women are diagnosed later in life. By the time many women receive an ADHD diagnosis in adulthood, they have spent years or decades compensating at significant psychological cost, often accumulating diagnoses of anxiety or depression that were treated as standalone conditions rather than recognized as traveling alongside undiagnosed ADHD.
Medication Response Is Not Identical
Emerging evidence suggests that stimulant medications may work somewhat differently depending on sex. Prepubertal girls may show a stronger initial response to stimulants and an earlier decline in effects compared to boys, with these differences becoming more pronounced during puberty. After 24 months on methylphenidate, girls showed lower symptom severity as rated by parents and clinicians, along with better focused attention regardless of dose.
Side effect profiles also diverge. A large pharmacovigilance analysis found that females over 13 using common ADHD medications reported more frequent adverse events overall. Males reported more cardiovascular and fertility-related side effects, while females reported higher rates of withdrawal symptoms, depression, restlessness, and convulsions. The hormonal fluctuations described earlier likely play a role, as shifting estrogen levels can change how effectively stimulant medications work from week to week within the same menstrual cycle.
Long-Term Impact on Career and Well-Being
Inattention symptoms in emerging adulthood predicted precarious employment in early middle adulthood for both sexes, but the pathway from symptoms to life satisfaction differed. For men, inattention was significantly linked to lower career satisfaction, while hyperactivity-impulsivity showed only a borderline association. For women, both inattention and hyperactivity-impulsivity were significantly associated with career satisfaction, but interestingly, hyperactivity-impulsivity had a positive association, suggesting that the drive and energy component of ADHD may function differently for women in professional settings.
Both men and women with ADHD symptoms showed a dose-response relationship with comorbid psychiatric conditions: more symptoms meant higher likelihood of generalized anxiety, major depression, and substance use disorders. But adolescent girls with ADHD are at higher risk for mental health problems than both boys with the same diagnoses and neurotypical girls, placing them in a uniquely vulnerable position, particularly when the condition goes unrecognized.